In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent
Michele Baccarani(University of Bologna), Francesco Passamonti(University of Milan), Audrey Bidet(Centre Hospitalier Universitaire de Bordeaux), Neelam Varma(Nagpur Institute of Technology), Poonkuzhali Balasubramanian(Christian Medical College, Vellore), Monica Crugnola(Ospedale di Parma), Mario Luppi(University of Modena and Reggio Emilia), Robin Foà(Sapienza University of Rome), Letizia Foroni(Centre for Inflammation Research), Orietta Spinelli(Ospedale Papa Giovanni XXIII), Victor Salinas-Viedma(IPS Central), Ombretta Annibali(Link Campus University), Jeroen J. W. M. Janssen(Radboud University Nijmegen), Beatrice Borsellino(University of Rome Tor Vergata), Mario Annunziata(Ospedale Antonio Cardarelli), Barbara Scappini(Azienda Ospedaliero-Universitaria Careggi), Francesco Di Raimondo(University of Catania), Renata Zadro(University Hospital Centre Zagreb), Carolina Terragna(Fondazione Gimema Onlus), Barbara Izzo(Centre de Recherche Jean Pierre Aubert), Sabina Chiaretti(Sapienza University of Rome), Samia Menif(Institut Pasteur de Tunis), Thomas Lion(Ludwig Boltzmann Institute for Cancer Research), Behzad Poopak(Islamic Azad University, Tehran), Tulika Seth(All India Institute of Medical Sciences), Valentina Polli(Ospedale Infermi di Rimini), Stephen E. Langabeer(St. James's Hospital), Jiřı́ Mayer(Masaryk University), Daniel Coriu(Carol Davila University of Medicine and Pharmacy), Ilaria Iacobucci(St. Jude Children's Research Hospital), Francesco Albano(University of Bari Aldo Moro), Ana Inés Prado(Hospital Maciel), Lorenzo Comba(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Giovanna Rege‐Cambrin, Elisabeth Paietta(Montefiore Medical Center), Francesca Lunghi(Vita-Salute San Raffaele University), Sabine Jeromin(Heidelberg University), Jacqueline Maier(Leipzig University), Alexis Márquez Ayala(Universidad Nacional de Asunción), B. Milner(NHS Grampian), Irena Zupan(Ljubljana University Medical Centre), Sara Galimberti(University of Pisa), Emma Burt(Royal London Hospital), Anna Candoni(University of Udine)
Cited by 9
Related Papers
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k